To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1288372
Sale price229,01 €
|
Ganoderma lucidum Fruiting Body Dry Extract (1 g) |
F012B0 | N/A | 229,01 € | |
|
USP-1288419
Sale price941,76 €
|
Gatifloxacin Related Compound A (15 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) |
F06770 | 616205-76-6 | 941,76 € | |
|
USP-1288441
Sale price999,02 €
|
Gatifloxacin Related Compound D (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) |
F067A0 | 112811-57-1 | 999,02 € | |
|
USP-1288452
Sale price1.070,29 €
|
Gatifloxacin Related Compound E (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride) |
F045U0 | 1219097-41-2 | 1.070,29 € | |
|
USP-1288510
Sale price1.050,43 €
|
Gemfibrozil Related Compound A (20 mg) ((E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid) |
R200N0 | 500904-61-0 | 1.050,43 € | |
|
USP-1288634
Sale price1.101,84 €
|
Gemifloxacin Related Compound B (15 mg) (7-[3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate) |
F13180 | N/A | 1.101,84 € | |
|
USP-1288645
Sale price1.101,84 €
|
Gemifloxacin Related Compound C (15 mg) (7-[3-(Aminomethyl)-4-oxopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate) |
F13190 | N/A | 1.101,84 € | |
|
USP-1289116
Sale price969,81 €
|
Gefitinib Related Compound A (25 mg) (7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one) |
F180R0 | 199327-61-2 | 969,81 € | |
|
USP-1289127
Sale price969,81 €
|
Gefitinib Related Compound B (25 mg) (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazoline-4-amine) |
F180S0 | 1603814-04-5 | 969,81 € | |
|
USP-1291446
Sale price487,24 €
|
Ginger Constituent Mixture (0.6 mg) (A freeze-dried mixture of 6-Gingerol and 6-Shogaol) |
R09440 | N/A | 487,24 € | |
|
USP-1291548
Sale price352,87 €
|
Ginkgolic Acids (20 mg) (Mixture of ginkgolic acid C13:0, ginkgolic acid C15:1 and ginkgolic acid C17:1) |
R082K0 | N/A | 352,87 € |
